Fortrea (FTRE) Competitors $8.04 +0.14 (+1.77%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$8.04 0.00 (0.00%) As of 08/15/2025 06:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTRE vs. VCYT, ADUS, PGNY, CELC, ARDT, LFST, PACS, NHC, VRDN, and AVAHShould you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include Veracyte (VCYT), Addus HomeCare (ADUS), Progyny (PGNY), Celcuity (CELC), Ardent Health (ARDT), LifeStance Health Group (LFST), PACS Group (PACS), National HealthCare (NHC), Viridian Therapeutics (VRDN), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry. Fortrea vs. Its Competitors Veracyte Addus HomeCare Progyny Celcuity Ardent Health LifeStance Health Group PACS Group National HealthCare Viridian Therapeutics Aveanna Healthcare Veracyte (NASDAQ:VCYT) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment. Which has more volatility and risk, VCYT or FTRE? Veracyte has a beta of 1.97, meaning that its stock price is 97% more volatile than the S&P 500. Comparatively, Fortrea has a beta of 1.81, meaning that its stock price is 81% more volatile than the S&P 500. Is VCYT or FTRE more profitable? Veracyte has a net margin of 5.50% compared to Fortrea's net margin of -37.57%. Veracyte's return on equity of 6.07% beat Fortrea's return on equity.Company Net Margins Return on Equity Return on Assets Veracyte5.50% 6.07% 5.53% Fortrea -37.57%5.25%1.72% Which has preferable valuation and earnings, VCYT or FTRE? Veracyte has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeracyte$445.76M5.33$24.14M$0.3391.58Fortrea$2.70B0.27-$328.50M-$11.38-0.71 Do analysts recommend VCYT or FTRE? Veracyte currently has a consensus target price of $40.90, indicating a potential upside of 35.34%. Fortrea has a consensus target price of $13.30, indicating a potential upside of 65.42%. Given Fortrea's higher possible upside, analysts plainly believe Fortrea is more favorable than Veracyte.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veracyte 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Fortrea 1 Sell rating(s) 10 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.15 Does the media prefer VCYT or FTRE? In the previous week, Fortrea had 12 more articles in the media than Veracyte. MarketBeat recorded 19 mentions for Fortrea and 7 mentions for Veracyte. Fortrea's average media sentiment score of 1.16 beat Veracyte's score of 0.96 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 7 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryVeracyte beats Fortrea on 10 of the 15 factors compared between the two stocks. Get Fortrea News Delivered to You Automatically Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTRE vs. The Competition Export to ExcelMetricFortreaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$730.03M$3.14B$5.72B$9.79BDividend YieldN/A2.21%3.91%4.13%P/E Ratio-0.7121.0331.1425.06Price / Sales0.27288.71417.8391.01Price / Cash5.1142.6136.7858.67Price / Book1.248.659.086.18Net Income-$328.50M-$54.65M$3.26B$265.11M7 Day Performance22.19%6.56%7.39%4.22%1 Month Performance62.42%4.82%4.22%0.77%1 Year Performance-63.91%15.81%30.30%24.69% Fortrea Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTREFortrea3.9745 of 5 stars$8.04+1.8%$13.30+65.4%-63.9%$730.03M$2.70B-0.7115,500Positive NewsVCYTVeracyte2.7968 of 5 stars$27.99+2.3%$40.90+46.1%-8.0%$2.15B$445.76M84.82790News CoverageADUSAddus HomeCare4.7965 of 5 stars$111.95+1.6%$142.86+27.6%-12.4%$2.03B$1.15B24.7149,703PGNYProgyny1.4657 of 5 stars$21.75-4.8%$24.90+14.5%+11.2%$1.96B$1.17B36.86310CELCCelcuity1.1178 of 5 stars$46.66+1.7%$39.20-16.0%+212.9%$1.79BN/A-15.4040News CoverageEarnings ReportAnalyst ForecastShort Interest ↑ARDTArdent Health3.2438 of 5 stars$12.04+1.3%$19.55+62.4%-26.3%$1.70B$5.97B6.6524,900LFSTLifeStance Health Group3.2268 of 5 stars$4.57+4.6%$8.50+86.0%-3.7%$1.70B$1.25B-91.4010,218PACSPACS Group2.4616 of 5 stars$11.35+1.9%$34.29+202.0%-70.3%$1.70B$3.11B0.0032,433NHCNational HealthCareN/A$103.43+3.0%N/A-15.5%$1.60B$1.37B12.9612,400Dividend AnnouncementVRDNViridian Therapeutics1.7319 of 5 stars$16.89+2.9%$37.00+119.1%+19.7%$1.34B$300K-4.4150AVAHAveanna Healthcare1.9033 of 5 stars$6.83+11.2%$6.10-10.7%+42.5%$1.28B$2.02B85.3833,500News CoverageAnalyst Forecast Related Companies and Tools Related Companies VCYT Competitors ADUS Competitors PGNY Competitors CELC Competitors ARDT Competitors LFST Competitors PACS Competitors NHC Competitors VRDN Competitors AVAH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTRE) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access